rss
Eur J Hosp Pharm 20:125-128 doi:10.1136/ejhpharm-2012-000209
  • Research
  • Short report

Are we using oxycodone appropriately? A utilisation review in a UK tertiary care centre

  1. I Andrew1,3
  1. 1Department of Pharmacy, Health and Wellbeing, University of Sunderland, Sunderland, UK
  2. 2Division of Pharmacy, School of Medicine, Pharmacy and Health
  3. 3St Benedict's Hospice, Monkwearmouth Hospital, Sunderland, UK.
  1. Correspondence to Dr Adam Todd, Division of Pharmacy, School of Medicine, Pharmacy and Health Durham University, Wolfson Research Institute, Stockton-on-Tees TS17 6BH, UK; adam.todd{at}durham.ac.uk
  • Received 21 August 2012
  • Revised 21 September 2012
  • Accepted 24 September 2012
  • Published Online First 30 October 2012

Abstract

Objectives To evaluate the utilisation of oxycodone in a tertiary care centre based in the North of England serving a population of 330 000.

Methods A prospective study which gathered data from October 2011 to March 2012. Medical notes were screened to determine the prevalence of oxycodone use during the study period. The medication histories were determined; once the reason for oxycodone initiation was established, it was interpreted and classified as either appropriate or inappropriate.

Results During the study period, a total of 51 patients were taking oxycodone; one patient was lost to follow-up. General practitioners were found to be the most common group responsible for initiating oxycodone (22 patients, 44%), followed by specialist palliative care nurses (11 patients, 22%). Other prescribers included palliative care consultants (nine patients, 18%); hospital doctors (seven patients, 14%) and a site-specific specialist nurse (one patient, 2%). Of the 50 patients, 17 (34%) were considered to be using oxycodone inappropriately. The most frequent reason for inappropriate use was initiating oxycodone without initially trying morphine.

Conclusions Oxycodone is initiated inappropriately in a significant number of palliative care patients and should only be used as a second-line strong opioid or if morphine is not suitable or cannot be tolerated. The specialist palliative care team should be consulted for advice in cases of complex pain management.

EJHP blog

Analysis and discussion of the latest news, research findings and policy developments in hospital pharmacy.

Visit the blog >>

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EJHP.

View free sample issue >>

Email alerts

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article